Pterin transport and metabolism in Leishmania and related trypanosomatid parasites

International Journal for Parasitology

Volumn 32, Issue 4, 2002, Pages 385-398

  Ouellette, Marc ^a,b   Drummelsmith, Jolyne ^a,b   El Fadili, Amal ^a,b   Kündig, Christoph ^a,b   Richard, Dave ^a,b   Roy, Gaétan ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Biopterin; Cellular transport; Drug resistance; Folate metabolism; Leishmania; Methotrexate

Indexed keywords

AMINO ACID; CARRIER PROTEIN; DIHYDROFOLATE REDUCTASE; ENZYME; FOLIC ACID; GENE PRODUCT; GLYCEROL ETHER; GLYCINE HYDROXYMETHYLTRANSFERASE; GROWTH FACTOR; METHIONINE; METHOTREXATE; MOLYBDOPTERIN; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; OXIDOREDUCTASE; OXYGENASE; PTERIN; PTEROPTIN; THYMIDYLATE SYNTHASE; UNSPECIFIC MONOOXYGENASE;

METABOLISM;

ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; CHEMOTHERAPY; DIFFERENTIATION; DRUG DEVELOPMENT; GENOME; LEISHMANIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TRYPANOSOMA;

ANIMALS; BIOLOGICAL TRANSPORT; FOLIC ACID; LEISHMANIA; PTERINS; TRYPANOSOMATINA;

TRYPANOSOMATIDAE;

EID: 0036176478     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(01)00346-0     Document Type: Review

References (121)

1. Compartmentation of folate-mediated one-carbon metabolism in eukaryotes
2. Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells
3. Presence of methylenetetrahydrofolate reductase of American Leishmania species and its absence from Trypanosoma species
4. Isolation of a nitric oxide synthase from the protozoan parasite, Leishmania donovani
5. Nutritional requirements of wild-type and folate transport-deficient Leishmania donovani for pterins and folates
6. Biopterin conversion to reduced folates by Leishmania donovani promastigotes
7. PTR1: A reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major
8. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene
9. Recurrent de novo appearance of small linear DNAs in Leishmania major and relationship to extra-chromosomal DNAs in other species
10. Unstable DNA amplifications in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalise during stabilization
11. Primary structure of the gene encoding the bifunctional dihydrofolate reductase-thymidylate synthase of Leishmania major
12. Life in vacuoles - Nutrient acquisition by Leishmania amastigotes
13. A member of the aldoketo reductase family confers methotrexate resistance in Leishmania
14. Purification and partial characterization of three isoforms of serine hydroxymethyltransferase from Crithidia fasciculata
15. Purification and some properties of serine hydroxymethyltransferase from Trypanosoma cruzi
16. Mutant PTR1 proteins from Leishmania tarentolae: Comparative kinetic properties and active-site labeling
17. Amplification of the H locus in Leishmania infantum
18. Novel inhibitors of Leishmanial dihydrofolate reductase
19. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase
20. Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica
21. Double targeted gene replacement for creating null mutants
22. Plasticity in chromosome number and testing of essential genes in Leishmania by targeting
23. Pteridine salvage throughout the Leishmania infectious cycle: Implications for antifolate chemotherapy
24. Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin
25. DNA amplification in arsenite-resistant Leishmania
26. Impaired drug uptake in methotrexate resistant Crithidia fasciculata without changes in dihydrofolate reductase activity or gene amplification
27. An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae
28. Immunization with recombinant LD1 antigens protects against experimental leishmaniasis
29. Biochemistry and regulation of folate and methotrexate transport in Leishmania major
30. Reductions in methotrexate and folate influx in methotrexate-resistant lines of Leishmania major are independent of R or H region amplification
31. Multiple drug resistance and conservative amplification of the H region in Leishmania major
32. Wild-type and drug-resistant Leishmania major hydrolyse methotrexate to N-10-methyl-4-deoxy-4-aminopteroate without accumulation of methotrexate polyglutamates
33. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis
34. Dihydrofolate reductase: Thymidylate synthase, a bifunctional polypeptide from Crithidia fasciculata
35. Tetrahydropterin-dependent amino acid hydroxylases
36. P-glycoprotein overexpression in methotrexate-resistant Leishmania tropica
37. A novel interaction of the Golgi complex with the vimentin intermediate filament cytoskeleton
38. Nitric oxide synthase is induced in sporulation of Physarum polycephalum
39. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression
40. A new VSG expression site-associated gene (ESAG) in the promoter region of Trypanosoma brucei encodes a protein with 10 potential transmembrane domains
41. Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites
42. Drug resistance in leishmaniasis: Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease
43. Linear amplicons as precursors of amplified circles in methotrexate-resistant Leishmania tarentolae
44. Formation of extrachromosomal circular amplicons with direct or inverted duplications in drug-resistant Leishmania tarentolae
45. Bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania tropica: Sequence homology with the corresponding monofunctional proteins
46. The G alpha subunit G alpha 4 couples to pterin receptors and identifies a signaling pathway that is essential for multicellular development in Dictyostelium
47. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae
48. Purine and pyrimidine metabolism in the Trypanosomatidae
49. Leishmaniasis: Current status of vaccine development
50. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways
51. Leishmaniasis
52. Extrachromosomal elements in the lower eukaryote Leishmania
53. Dihydropteridine reductase and tetrahydropterin in Crithidia fasciculata cells
54. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
55. Intermediates in the folic acid biosynthetic pathway are incorporated into molybdopterin the yeast, Pichia canadensis
56. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy
57. Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India
58. Short-chain dehydrogenases/reductases (SDR)
59. Dependence of an alkyl glycol-ether monooxygenase activity upon tetrahydropterins
60. Methotrexate-resistant Leishmania donovani genetically deficient in the folate-methotrexate transporter
61. Relationship between pyrimidine and lipid biosynthesis and unconjugated pteridines
62. The growth and nutrition of Crithidia fasciculata
63. A structural comparison of molybdenum cofactor-containing enzymes
64. Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidylate synthase
65. Antioxidative activity of 5,6,7,8-tetrahydrobiopterin and its inhibitory effect on paraquat-induced cell toxicity in cultured rat hepatocytes
66. Resistance to methotrexate due to AcrAB-dependent export from Escherichia coli
67. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: Potential for screening therapeutic agents
68. Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae
69. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae
70. Residues involved in co-factor and substrate binding of the short-chain dehydrogenase/reductase PTR1 producing methotrexate resistance in Leishmania
71. Characterization of three genes encoding enzymes of the folate biosynthetic pathway in Plasmodium falciparum
72. The Leishmania ABC protein PGPA is an intracellular metal-thiol transporter ATPase
73. The Leishmania donovani LD1 locus gene ORFG encodes a biopterin transporter (BT1)
74. Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase
75. Evidence that the high incidence of treatment failures in Indian Kala-Azar is due to the emergence of antimony-resistant strains of Leishmania donovani
76. Gamma-glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias
77. Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters
78. Catalysis by nitric oxide synthase
79. Purification and characterization of the bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexate-resistant Leishmania tropica
80. Roles of folylpoly-gamma-glutamate synthetase in therapeutics with tetrahydrofolate antimetabolites: An overview
81. Treatment of visceral leishmaniasis (kala-azar): A decade of progress and future approaches
82. An amplified DNA element in Leishmania encodes potential integral membrane and nucleotide-binding proteins
83. Tetrahydrobiopterin scavenges superoxide in dopaminergic neurons
84. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major
85. New approaches to Leishmania chemotherapy: Pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity
86. Serine hydroxymethyltransferase activity in Trypanosoma cruzi, Trypanosoma rangeli and American Leishmania spp.
87. Radioassay of the folate-hydrolyzing enzyme activity, and the distribution of the enzyme in biological cells and tissues
88. The amplified H circle of methotrexate-resistant leishmania tarentolae contains a novel P-glycoprotein gene
89. Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania
90. Antifolate resistance mechanisms from bacteria to cancer cells with emphasis on parasites
91. Frequent amplification of a short chain dehydrogenase gene in methotrexate resistant Leishmania
92. Reduced infectivity of a Leishmania donovani biopterin transporter BT1 genetic mutant and its use as an attenuated strain for vaccination
93. Changes in folate and pterin metabolism after disruption of the Leishmania H locus short chain dehydrogenase gene
94. A novel antifolate resistance gene on the amplified H circle of Leishmania
95. Frequent amplification of a short chain dehydrogenase gene as part of circular and linear amplicons in methotrexate resistant Leishmania
96. In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes
97. Amplified DNAs in laboratory stocks of Leishmania tarentolae: Extrachromosomal circles structurally and functionally similar to the inverted-H-region amplification of methotrexate-resistant Leishmania major
98. Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity
99. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi
100. Adaptation of leishmania cells to in vitro culture results in a more efficient reduction and transport of biopterin
101. Aberrant folate response and premature development in a mutant of Dictyostelium discoideum
102. Folylpolyglutamates in Leishmania major
103. Identification of efflux systems for large anions and anionic conjugates as the mediators of methotrexate efflux in L1210 cells
104. Folate utilisation by Leishmania species and the identification of intracellular derivatives and folate-metabolising enzymes
105. LD1 amplifications in Leishmania
106. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism
107. Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines
108. Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms
109. Failure of pentavalent antimony in visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic
110. Tetrahydrobiopterin biosynthesis, regeneration and functions
111. Development of a safe live Leishmania vaccine line by gene replacement
112. Pteridine requirement of the hemoflagellate Leishmania tarentolae
113. A DNA sequence (LD1) which occurs in several genomic organizations in Leishmania
114. The lipophosphoglycan of Leishmania parasites
115. Structural and mechanistic characteristics of dihydropteridine reductase: A member of the Tyr-(Xaa)3-Lys-containing family of reductases and dehydrogenases
116. Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo
117. Pterin and folate reduction by the Leishmania tarentolae H locus short-chain dehydrogenase/reductase PTR1
118. The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance
119. Investigation of the early steps of molybdopterin biosynthesis in Escherichia coli through the use of in vivo labeling studies
120. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells
121. Dihydrofolate reductase: A potential drug target in trypanosomes and Leishmania